Human Mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE 2 -dependent mechanism

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Vasandan, Anoop Babu ^a   Jahnavi, Sowmya ^a   Shashank, Chandanala ^a   Prasad, Priya ^a   Kumar, Anujith ^a   Jyothi Prasanna, S ^a  

^a MANIPAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; GLUCOSE TRANSPORTER 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3-DIOXYGENASE 1, HUMAN; MTOR PROTEIN, HUMAN; PROSTAGLANDIN E2; PTGS2 PROTEIN, HUMAN; SIRT1 PROTEIN, HUMAN; SIRTUIN 1; SLC2A1 PROTEIN, HUMAN; SMALL INTERFERING RNA; TARGET OF RAPAMYCIN KINASE;

CELL COMMUNICATION; CELL DIFFERENTIATION; COCULTURE; CONDITIONED MEDIUM; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MACROPHAGE; MACROPHAGE ACTIVATION; MESENCHYMAL STROMA CELL; METABOLISM; PHAGOCYTOSIS; PHARMACOLOGY; PRIMARY CELL CULTURE; SALMONELLA ENTERICA; SECRETION (PROCESS); SIGNAL TRANSDUCTION; THP-1 CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL;

AMP-ACTIVATED PROTEIN KINASES; CELL COMMUNICATION; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 1; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MACROPHAGE ACTIVATION; MACROPHAGES; MESENCHYMAL STROMAL CELLS; PHAGOCYTOSIS; PRIMARY CELL CULTURE; RNA, SMALL INTERFERING; SALMONELLA ENTERICA; SIGNAL TRANSDUCTION; SIRTUIN 1; THP-1 CELLS; TOR SERINE-THREONINE KINASES;

EID: 85002748928     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep38308     Document Type: Article

References (56)

1. Pull, S. L., Doherty, J. M., Mills, J. C., Gordon, J. I. & Stappenbeck, T. S. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc. Natl. Acad. Sci. 102, 99-104 (2005).
2. Nahrendorf, M. et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204, 3037-3047 (2007).
3. Lucas, T. et al. Differential roles of macrophages in diverse phases of skin repair. J. Immunol. 184, 3964-3977 (2010).
4. Salem, H. K. & Thiemermann, C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells. 28, 585-596 (2010).
5. Maxson, S., Lopez, E. A., Yoo, D., Danilkovitch-Miagkova, A. & Leroux, M. A. Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Transl. Med. 1, 142-149 (2012).
6. Knaän-Shanzer, S. Concise review: the immune status of mesenchymal stem cells and its relevance for therapeutic application. Stem Cells. 32, 603-608 (2014).
7. Phinney, D. G. & Prockop, D. J. Mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells. 25, 2896-2902 (2007).
8. Morando, S. et al. The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms. Stem Cell Res. Ther. 3, 1-7 (2012).
9. Ezquer, F. et al. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment. Stem Cells. 30, 1664-1674 (2012).
10. Ren, G. et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2, 141-150 (2008).
11. Liu, Y. et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-? and TNF-A . Nat. Med. 17, 1594-1601 (2011).
12. Chao, Y. H. et al. An increase in CD3 + CD4 + CD25 + regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis. PLoS One. 9, e110338 (2014).
13. Wang, Z. X. et al. Mesenchymal stem cells alleviate atherosclerosis by elevating number and function of CD4(+ )CD25 (+ )FOXP3 (+ ) regulatory T-cells and inhibiting macrophage foam cell formation. Mol. Cell Biochem. 400, 163-172 (2015).
14. Lopez-Santalla, M. et al. Human Adipose-Derived mesenchymal stem cells modulate experimental autoimmune arthritis by modifying early adaptive T cell responses. Stem Cells. 33, 3493-3503 (2015).
15. Sieweke, M. H. & Allen, J. E. Beyond stem cells: self-renewal of differentiated macrophages. Science. 342, 1242974 (2013).
16. Parsa, R. et al. Adoptive transfer of immuno-modulatory M2 macrophages prevents type 1 diabetes in NOD mice. Diabetes. 61, 2881-2892 (2012).
17. Cao, X., Han, Z. B., Zhao, H. & Liu, Q. Transplantation of mesenchymal stem cells recruits trophic macrophages to induce pancreatic beta cell regeneration in diabetic mice. Int. J. Biochem. Cell Biol. 53, 372-379 (2014).
18. Xie, Z. et al. Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats. Stem Cells. 10, 2238 (2015).
19. Cho, D. I. et al. Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages. Exp. Mol. Med. 46, e70 (2014).
20. Dameshghi, S. et al. Mesenchymal stem cells alter macrophage immune responses to Leishmania major infection in both susceptible and resistance mice. Immunol. Lett. 170, 15-26 (2015).
21. Hu, Y. et al. Mesenchymal Stem Cell-Educated Macrophages Ameliorate LPS-Induced Systemic Response. Mediators Inflamm. 2016, 3735452 (2016).
22. Takashiba, S. et al. Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cytoplasmic nuclear factor kappaB. Infect. Immun. 67, 5573-5578 (1999).
23. Iles, K. E. & Forman, H. J. Macrophage signaling and respiratory burst. Immunol. Res. 26, 95-105 (2002).
24. Satoh, T. et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11, 936-944 (2010).
25. Mosser, D. M. The many faces of macrophage activation. J. Leukoc. Biol. 73, 209-212 (2003).
26. Wang, X. F. et al. The role of indoleamine 2, 3-dioxygenase (IDO) in immune tolerance: focus on macrophage polarization of THP-1 cells. Cell Immunol. 289, 42-48 (2014).
27. Kelly, B. & O'Neill, L. A. Review: Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 25, 771-784 (2015).
28. El Kasmi, K. C. & Stenmark, K. R. Review: Contribution of metabolic reprogramming to macrophage plasticity and function. Semin. Immunol. 27, 267-275 (2015).
29. Ohtani, M. et al. Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. Blood. 112, 635-643 (2008).
30. Yeung, F. et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369-2380 (2004).
31. Prasanna, S. J., Gopalakrishnan, D., Shankar, S. R. & Vasandan, A. B. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One. 5, e9016 (2010).
32. Rozenberg, A. et al. Human mesenchymal stem cells impact Th17 and Th1 responses through a prostaglandin E2 and myeloiddependent mechanism. Stem Cells Transl. Med. 5, 1-9 (2016).
33. Özdemir, A. T. et al. The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets. Cell Immunol. 8749, 30081-30088 (2016).
34. Fadini, G. P. et al. An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. Diabetologia. 56, 1856-1866 (2013).
35. Motomura, Y. et al. Identification of Pathogenic Cardiac CD11c + Macrophages in Nod1-Mediated Acute Coronary Arteritis. Arterioscler. Thromb. Vasc. Biol. 35, 1423-1433 (2015).
36. Mills, C. D., Kincaid. K., Alt, J. M., Heilman, M. J. & Hill, A. M. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164, 6166-6173 (2000).
37. Lu, W. et al. Exposure to supernatants of macrophages that phagocytized dead mesenchymal stem cells improves hypoxic cardiomyocytes survival. Int. J. Cardiol. 165, 333-340 (2013).
38. Eggenhofer, E., Luk, F., Dahlke, M. H. & Hoogduijn, M. J. The life and fate of mesenchymal stem cells. Front. Immunol. 5, 148 (2014).
39. Németh, K. et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15, 42-49 (2009).
40. Choi, H., Lee, R. H., Bazhanov, N., Oh, J. Y. & Prockop, D. J. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-? B signaling in resident macrophages. Blood. 118, 330-338 (2011).
41. Kim, J. & Hematti, P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp. Hematol. 37, 1445-1453 (2009).
42. Ti, D. et al. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization forresolution of chronic inflammation via exosome-shuttled let-7b. J. Transl. Med. 13, 308 (2015).
43. Zhang, Q. Z. et al. Human gingiva-derived mesenchymal stem cells elicit polarization of M2 macrophages and enhance cutaneous wound healing. Stem Cells. 28, 1856-1868 (2010).
44. Murray, P. J. & Wynn, T. A. Review: Obstacles and opportunities for understanding macrophage polarization. J. Leukoc. Biol. 89, 557-563 (2011).
45. Abumaree, M. H. et al. Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages. Stem Cell Rev. 9, 620-641 (2013).
46. Zhang, Y. et al. et al. Potent Paracrine Effects of human induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells Attenuate Doxorubicin-induced Cardiomyopathy. Sci. Rep. 9, 11235 (2015).
47. Freemerman, A. J. et al. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J. Biol. Chem. 289, 7884-7896 (2014).
48. Carroll, K. C., Viollet, B. & Suttles, J. AMPKalpha1 deficiency amplifies proinflammatory myeloid APC activity and CD40 signaling. J. Leukoc. Biol. 94, 1113-1121 (2013).
49. Kawada, M. et al. Stromal cells positively and negatively modulate the growth of cancer cells: stimulation via the PGE2-TNFa-IL-6 pathway and inhibition via secreted GAPDH-E-cadherin interaction. PLoS One. 10, e0119415 (2015).
50. Hosono, K., Isonaka, R., Kawakami, T., Narumiya, S. & Majima, M. Signaling of Prostaglandin E Receptors, EP3 and EP4 Facilitates Wound Healing and Lymphangiogenesis with Enhanced Recruitment of M2 Macrophages in Mice. PLoS ONE 11, e0162532 (2016).
51. Vasandan, A. B. et al. Functional differences in mesenchymal stromal cells from human dental pulp and periodontal ligament. J. Cell Mol. Med. 18, 344-354 (2014).
52. Auwerx, J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia. 47, 22-31 (1991).
53. Nakagawa, T. et al. Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages. Arterioscler. Thromb. Vasc. Biol. 18, 1350-1357 (1998).
54. Martinez, F. O., Gordon, S., Locati, M. & Mantovani, A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303-7311 (2006).
55. Allen, R. G. et al. Stressor-induced increase in microbicidal activity of splenic macrophages is dependent upon peroxynitrite production. Infect. Immun. 80, 3429-3437 (2012).
56. Krishan, A. Rapid flow cyto-fluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66, 188-193 (1975).